cmv 16 E7 Citations (2)

Originally described in: Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7.
Gonzalez SL, Stremlau M, He X, Basile JR, Munger K J Virol. 2001 Aug . 75(16):7583-91. PubMed Journal

---

Articles Citing cmv 16 E7

Articles
HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING. Luo X, Donnelly CR, Gong W, Heath BR, Hao Y, Donnelly LA, Moghbeli T, Tan YS, Lin X, Bellile E, Kansy BA, Carey TE, Brenner JC, Cheng L, Polverini PJ, Morgan MA, Wen H, Prince ME, Ferris RL, Xie Y, Young S, Wolf GT, Chen Q, Lei YL. J Clin Invest. 2020 Apr 1;130(4):1635-1652. doi: 10.1172/JCI129497. PubMed
HPV upregulates MARCHF8 ubiquitin ligase and inhibits apoptosis by degrading the death receptors in head and neck cancer. Khalil MI, Yang C, Vu L, Chadha S, Nabors H, Welbon C, James CD, Morgan IM, Spanos WC, Pyeon D. PLoS Pathog. 2023 Mar 3;19(3):e1011171. doi: 10.1371/journal.ppat.1011171. eCollection 2023 Mar. PubMed

If you have published an article using this material, please email us at to have your article added to this page.